Quoin Pharmaceuticals QNRX
NASDAQ QNRX
$4.01 -0.10 (-2.43%)
As of: Oct 22, 2026 · 2:36 PM EDT

Quoin Pharmaceuticals (QNRX) Long-Term Debt Repayments (2021 - 2026)

Updated

Quoin Pharmaceuticals (QNRX) reported Long-Term Debt Repayments of $150,000 for the quarter ended Jun 30, 2026, unchanged from $150,000 a year earlier and unchanged from the prior quarter.

Analysis

Quoin Pharmaceuticals (QNRX) Long-Term Debt Repayments (2021 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Quoin Pharmaceuticals' Long-Term Debt Repayments came in at $600,000, unchanged year-over-year; for the year ended Dec 31, 2025, it was $600,000, unchanged from the prior year.

  • Long-Term Debt Repayments has a five-year compound annual growth rate of 64.4% (years ended Dec 2020 to Dec 2025).
  • By year, Long-Term Debt Repayments came in at $600,000 in the year ended Dec 31, 2024 (unchanged), $600,000 in the year ended Dec 31, 2023 (unchanged), $599,999 in the year ended Dec 31, 2022 (+97.1%) and $304,466 in the year ended Dec 31, 2021 (+508.9%).
  • Five-year quarterly Long-Term Debt Repayments spans a low of $75,000 in the quarter ended Jun 30, 2023 and a high of $275,000 in the quarter ended Sep 30, 2023.
  • The high point for year-over-year Long-Term Debt Repayments in five years was the quarter ended Jun 30, 2024 (growth of 100.0%); the low point was the quarter ended Jun 30, 2023 (a decline of 50.0%).
  • Per Business Quant data, the three quarters before the quarter ended Jun 30, 2026 came in at $150,000 (quarter ended Mar 31, 2026), $150,000 (quarter ended Dec 31, 2025) and $150,000 (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 873.00 Mn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 1.00 Mn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 2.00 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 5.00 Mn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 20.00 Mn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 2.46 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 17.00 Mn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -
10 Quoin Pharmaceuticals 324,571.14 -45.14 Mn - 150,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 150,000.00
Mar 31, 2026 150,000.00
Dec 31, 2025 150,000.00
Sep 30, 2025 150,000.00
Jun 30, 2025 150,000.00
Mar 31, 2025 150,000.00
Dec 31, 2024 150,000.00
Sep 30, 2024 150,000.00
Jun 30, 2024 150,000.00
Mar 31, 2024 150,000.00
Dec 31, 2023 150,000.00
Sep 30, 2023 275,000.00
Jun 30, 2023 75,000.00
Mar 31, 2023 100,000.00
Dec 31, 2022 461,670.00
Sep 30, 2022 149,999.00
Jun 30, 2022 150,000.00
Mar 31, 2022 150,000.00
Dec 31, 2021 150,000.00
API Access

Quoin Pharmaceuticals Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=QNRX&period=max&api_key=YOUR_API_KEY